Cialis erectile dysfunction treatment moves closer to approval -
Pharma Industry News ... Lilly ICOS is seeking approval of Cialis (pronounced: se-al-is), its investigational oral PDE5 inhibitor, for the treatment of erectile dysfunction. FDA approval is contingent upon successful completion of additional clinical pharmacology studies, labeling discussions and manufacturing inspections.
Buy CIALIS - Cialis impotence drug available now
Lilly ICOS' Cialis(R) (tadalafil) Reaches US$1 Billion Global Sales Milestone (Europa Press 07/21/05); Terrorist Attacks Cause More Damage Than Estimates Show (eMediaWire 07/16/05); Viagra, Cialis and Levitra Get New FDA Labelling, Slight Risk of Eye Problems (Medical News Today 07/09/05); House bans Medicare coverage...
CIALIS and Erectile Dysfunction News - Learn about Cialis
CIALIS is manufactured by Lilly/ICOS to treat erectile dysfunction. Update 5/20/2009 Latest Updates from the U.S. and UK. 5 Cialis tablets for $83. Find sites that carry brand name Cialis. Generic Cialis is dangerous. ... RECENT Cialis News and ED Information:
Cialis makes first market appearances in Europe, Australia and New
Pharma Industry News ... Sexual stimulation is needed for Cialis to work. According to the European label, the efficacy of Cialis may persist up to 24 hours after the pill is taken. In Australia the label indicates efficacy up to 36 hours after dosing.
Cialis Recent News - Accidents and Injuries
Find Cialis Recent News - Accidents and Injuries legal information and lawyers at FindLaw ... The U.S. Food and Drug Administration (FDA) announces that labeling on erectile dysfunction (ED) drugs Cialis, Levitra, and Viagra will more prominently display information on the potential risk of sudden hearing loss,
NOTE: Please contact us right away if you'd like to make any changes to your listing.
%INNERLINK%
Home | Index
|